1. Home
  2. NRP vs DNTH Comparison

NRP vs DNTH Comparison

Compare NRP & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRP
  • DNTH
  • Stock Information
  • Founded
  • NRP 2002
  • DNTH 2015
  • Country
  • NRP United States
  • DNTH United States
  • Employees
  • NRP N/A
  • DNTH N/A
  • Industry
  • NRP Coal Mining
  • DNTH Biotechnology: Pharmaceutical Preparations
  • Sector
  • NRP Energy
  • DNTH Health Care
  • Exchange
  • NRP Nasdaq
  • DNTH Nasdaq
  • Market Cap
  • NRP 1.4B
  • DNTH 1.4B
  • IPO Year
  • NRP N/A
  • DNTH N/A
  • Fundamental
  • Price
  • NRP $105.50
  • DNTH $36.28
  • Analyst Decision
  • NRP
  • DNTH Strong Buy
  • Analyst Count
  • NRP 0
  • DNTH 11
  • Target Price
  • NRP N/A
  • DNTH $65.44
  • AVG Volume (30 Days)
  • NRP 24.5K
  • DNTH 505.0K
  • Earning Date
  • NRP 11-04-2025
  • DNTH 11-05-2025
  • Dividend Yield
  • NRP 2.84%
  • DNTH N/A
  • EPS Growth
  • NRP N/A
  • DNTH N/A
  • EPS
  • NRP 10.92
  • DNTH N/A
  • Revenue
  • NRP $203,316,000.00
  • DNTH $3,078,000.00
  • Revenue This Year
  • NRP N/A
  • DNTH N/A
  • Revenue Next Year
  • NRP N/A
  • DNTH N/A
  • P/E Ratio
  • NRP $9.66
  • DNTH N/A
  • Revenue Growth
  • NRP N/A
  • DNTH N/A
  • 52 Week Low
  • NRP $86.83
  • DNTH $13.37
  • 52 Week High
  • NRP $113.04
  • DNTH $40.16
  • Technical
  • Relative Strength Index (RSI)
  • NRP 52.84
  • DNTH 58.59
  • Support Level
  • NRP $102.06
  • DNTH $32.56
  • Resistance Level
  • NRP $107.00
  • DNTH $37.47
  • Average True Range (ATR)
  • NRP 2.73
  • DNTH 1.69
  • MACD
  • NRP 0.08
  • DNTH 0.12
  • Stochastic Oscillator
  • NRP 58.03
  • DNTH 75.72

About NRP Natural Resource Partners LP Limited Partnership

Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. the majority of the revenue is generated from the Mineral Rights segment. Geographically, the business activity of the group functions through the United States.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

Share on Social Networks: